Atlas Genetics adds R&D expertise
This article was originally published in Clinica
UK IVD firm Atlas Genetics has appointed Daniel Adlerstein director of research and development. Mr Adlerstein joins the Bath-based company from Diasorin, where he worked for over a decade and held various product development roles. These roles include building Diasorin’s molecular diagnostics program and developing molecular tests and instruments in infectious diseases and oncology. Mr Adlerstein’s knowledge in this area will come in handy in his new position at Atlas, which is developing ultra-rapid point-of-care tests for a range of infectious diseases.